
Membio
Scalable single-use bioreactors.
Mississauga, Canada · Founded 2018 · $40K raised
- Headquarters
- Mississauga
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- membio.ca
- Total Funding
- $40K
- Last Round
- Pre-Seed
- Rounds
- 1
About
Membio developed proprietary single-use bioreactor technology purpose-built to enable cost-effective and scalable manufacturing of cells for cell therapy and gene therapy applications. Founded in 2018 in Mississauga, Ontario, the company focused on bioprocess development and R&D. In late 2023, Membio's bioreactor technology was acquired by ABEC Inc.
Summary
Membio is a Biotech company based in Mississauga, Canada, founded in 2018. It has raised $40K in total across 1 round. Investors include IndieBio and SOSV.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
